Collegium Pharmaceutical (COLL) Files $86.25M Common IPO

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) filed a registration with the U.S. SEC for an IPO of its Commmon Stock. The proposed maximum offering amount is $86.25 million. The company plans to list on the Nasdaq: under the ticker, COLL.

Underwriters on the offering include Jefferies, Piper Jaffray, Wells Fargo Securities, and Needham & Company.

Collegium Pharmaceutical is a specialty pharmaceutical company developing and planning to commercialize next-generation abuse-deterrent products that incorporate our patented DETERx® platform technology for the treatment of chronic pain and other diseases.

You May Also Be Interested In

• Parabilis Medicines closes $770.5 million IPO and concurrent private placement
• Cosmos Health signs letter of intent to acquire Doc Pharma for $24M
• Cosmos Health receives 180-day NASDAQ extension for bid price compliance